People · Operator

David J. Corcoran

Named in public records as an officer, director or promoter · active 2010–2012 · Pharmaceuticals, Manufacturing, Other Health Care

3
Companies
4
Filings
$2.1M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CURAXIS PHARMACEUTICAL CorpPharmaceuticalsSeed$1.5M$58.1M2010
International Barrier Technology IncManufacturingPre-Seed$409K$2.3M2010
Biohome Therapy, Inc.Other Health CarePre-Seed$200K$6.2M2012
Operator network

David J. Corcoran at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Patrick S. Smith · 2 companies · 2 sharedPatrick S. SmithJudy J Geaslen · 1 companies · 1 sharedJudy J GeaslenRonald Edward Pompeo · 1 companies · 1 sharedRonald Edward Pom…Sheldon L Goldberg · 1 companies · 1 sharedSheldon L GoldbergWilliam Edward McConville · 1 companies · 1 sharedWilliam Edward Mc…Craig J. Roberts · 2 companies · 1 sharedCraig J. RobertsLindsay J. Nauen · 1 companies · 1 sharedLindsay J. NauenMichael D Huddy · 1 companies · 1 sharedMichael D HuddyVictor J Yates · 1 companies · 1 sharedVictor J YatesCURAXIS PHARMACEUTICAL Corp · $1.5M raisedCURAXIS PHARMACEUTICA…International Barrier Technology Inc · $0.4M raisedInternational Barrier…Biohome Therapy, Inc. · $0.2M raisedBiohome Therapy, Inc.David J. CorcoranDC
David J. Corcoran Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside David J. Corcoran on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Patrick S. Smith22
Craig J. Roberts12
Victor J Yates11
Lindsay J. Nauen11
Sheldon L Goldberg11
Ronald Edward Pompeo11
William Edward McConville11
Judy J Geaslen11
Michael D Huddy11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.